drugset / Trial / NCT06018896
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy of vitamin C in improving the quality of life for metastatic pancreatic cancer patients who are resistant to chemotherapy.
Timeline
- Start
- 2023-08-25
- Primary completion
- 2025-08-15
- Completion
- 2026-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 900 mg | Intravenous |